mRNA |
selumetinib:navitoclax (8:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
tretinoin:navitoclax (4:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
ifosfamide |
CTRPv2 |
pan-cancer |
AAC |
0.027 |
0.6 |
mRNA |
CIL56 |
CTRPv2 |
pan-cancer |
AAC |
0.023 |
0.6 |
mRNA |
prochlorperazine |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
BRD-K85133207 |
CTRPv2 |
pan-cancer |
AAC |
0.019 |
0.6 |
mRNA |
navitoclax:MST-312 (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.018 |
0.6 |
mRNA |
TGX221 |
CTRPv2 |
pan-cancer |
AAC |
-0.019 |
0.6 |
mRNA |
navitoclax:sorafenib (1:1 mol/mol) |
CTRPv2 |
pan-cancer |
AAC |
0.017 |
0.6 |
mRNA |
Nilotinib |
CTRPv2 |
pan-cancer |
AAC |
-0.018 |
0.6 |